Table 1 Baseline characteristics of the participants
GROUPS (all participants Caucasian) | Group 1 N = 54 glucose > 3.9 mmol/L | Group 2 N = 25 glucose 3.9–3 mmol/L | Group 3 N = 15 glucose < 3.0 mmol/L | Pairwise comparison (p value) | |||||
|---|---|---|---|---|---|---|---|---|---|
Group 1 vs. Group 2 | Group 1 vs. Group 3 | Group 2 vs. Group 3 | |||||||
Median | SD | Median | SD | Median | SD | ||||
Age (years) | 64.50 | 8.03 | 67.00 | 8.55 | 63.00 | 8.63 | 0.17 | 0.86 | 0.24 |
BMI (kg/m2) | 30.43 | 40.51 | 28.88 | 4.98 | 29.80 | 2.90 | 0.25 | 0.30 | 0.47 |
Waist circumference (cm) | 102.00 | 11.00 | 98.00 | 11.93 | 105.00 | 12.41 | 0.47 | 0.16 | 0.19 |
Hip circumference (cm) | 110.00 | 11.42 | 106.00 | 12.12 | 104.00 | 6.18 | 0.07 | 0.05 | 0.38 |
Systolic BP (mmHg) | 130.00 | 11.36 | 130.00 | 9.95 | 130.00 | 14.60 | 0.33 | 0.10 | 0.18 |
Diastolic BP (mmHg) | 80.00 | 6.30 | 78.00 | 5.40 | 80.00 | 9.10 | 0.17 | 0.10 | 0.04 |
Pulse (beats/min) | 72.00 | 8.36 | 70.00 | 6.36 | 72.00 | 7.35 | 0.18 | 0.39 | 0.32 |
Gliclazide dosage (mg) | 15.00 | 34.46 | 45.00 | 36.00 | 60.00 | 47.93 | 0.22 | 0.12 | 0.32 |
Diabetes duration (years) | 6.00 | 5.48 | 8.00 | 5.02 | 7.00 | 3.99 | 0.07 | 0.43 | 0.14 |
A1C (%) | 7.00 | 1.13 | 6.90 | 0.83 | 7.10 | 0.95 | 0.22 | 0.40 | 0.17 |
eGFR MDRD (mL/min/1.73 m2) | 82.91 | 22.60 | 78.85 | 19.16 | 83.28 | 22.35 | 0.37 | 0.41 | 0.31 |
Fasting glucose (mmol/l) | 8.00 | 1.91 | 7.30 | 1.53 | 7.70 | 1.53 | 0.04 | 0.13 | 0.38 |